Breadcrumb
NIH Guide: Weekly Index for June 4, 2021
Weekly NIH Funding Opportunities and Notices
June 4, 2021
Policy Notices
-
RESCINDED - Updated Process for Submission of Federal Financial Reports for Closed Payment Management System Subaccounts
(NOT-OD-21-128)National Institutes of Health
-
RESCINDED - NIH Final Federal Financial Reports (FFRs) will be converted to Interim Annual Reports in the Payment Management System
(NOT-OD-21-138)National Institutes of Health
General Notices
-
Notice to Encourage Using AAALAC International Program Description Sections to Complete Parts of the OLAW Domestic Animal Welfare Assurance
(NOT-OD-21-130)National Institutes of Health
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Innovative Therapies and Tools for Screenable Disorders in Newborns
(NOT-HD-21-039)Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notices of Special Interest
-
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp- Clinical Trial Not Allowed)
(NOT-AR-22-003)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Special Interest (NOSI): Behavioral Economics for Implementation Research (BEIR) to improve use of Evidence-Based Practices for HLBS conditions
(NOT-HL-21-010)National Heart, Lung, and Blood Institute
Funding Opportunities
-
Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed)
(PAR-21-257)Office of the Director, NIHNational Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional)
(RFA-AA-21-007)National Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional)
(RFA-AA-21-008)National Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional)
(RFA-AA-21-009)National Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional)
(RFA-AA-21-010)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): August 16, 2021
-
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed)
(RFA-AA-21-011)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): August 16, 2021
-
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Resource (U24 Clinical Trial Not Allowed)
(RFA-AA-21-012)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): August 16, 2021
-
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Resource (U24 Clinical Trial Not Allowed)
(RFA-AA-21-013)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): August 16, 2021
-
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
(RFA-AA-21-014)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): August 16, 2021
-
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)
(RFA-CA-21-033)National Cancer InstituteApplication Receipt Date(s): September 9, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-CA-21-034)National Cancer InstituteApplication Receipt Date(s): September 9, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
(RFA-CA-21-035)National Cancer InstituteNational Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): September 9, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). No late applications will be accepted for this FOA.
-
Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed)
(RFA-DA-22-016)National Institute on Drug AbuseApplication Receipt Date(s): October 14, 2021
-
Characterization of Islet-derived Extracellular Vesicles for Improved Detection, Monitoring, Classification, and Treatment of Type 1 Diabetes (R01 Clinical Trial Not Allowed)
(RFA-DK-21-016)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): November 03, 2021
-
Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
(RFA-HG-21-026)National Human Genome Research InstituteNational Institute of Mental HealthDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): August 2, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
(RFA-RM-21-017)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): September 01, 2021
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: November 8, 2024
For technical issues E-mail OER Webmaster